Actively Recruiting

Age: 0 - 18Years
All Genders
ID01401998

Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource (ARPKD Database Study)

Led by Children's Hospital of Philadelphia · Updated on 2025-06-13

200

Participants Needed

6

Research Sites

13 weeks

Total Duration

On this page

Sponsors

C

Children's Hospital of Philadelphia

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are building a comprehensive registry for Hepato-Renal Fibrocystic Diseases (HRFD), which include rare conditions like Autosomal Recessive Polycystic Kidney Disease (ARPKD) and related disorders such as Joubert syndrome and congenital hepatic fibrosis. The goal is to gather clinical and genetic information and create educational resources to help families, doctors, and genetic counselors better understand these diseases. This observational study is designed to support research progress and community awareness through a shared database and biospecimen resources. Participants may choose to contribute to various parts of the study, including a clinical database, genetic testing, tissue donation, and educational resources. Medical records will be reviewed, with data entered into a secure database after removing personal identifiers. Blood or saliva samples may be collected from patients and their parents for genetic analysis, with samples stored at a specialized biorepository. Tissue samples from procedures like nephrectomy or autopsy may also be collected and stored for research. Participants will provide access to their medical information without needing to visit the study center. Data collection includes past, current, and future medical records, with annual updates for ongoing participation. Genetic and tissue samples will be stored and used to support research. The study team monitors the development of this resource over five years to enhance knowledge and treatment options for HRFD. Participation duration varies depending on continued involvement and consent.

CONDITIONS

Brief Title

ARPKD Database Study

Who Can Participate

Age: 0 - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of hepato/renal fibrocystic disease confirmed by clinical information, imaging studies, biopsy, autopsy, or genetic testing
Not Eligible

You will not qualify if you...

  • Autosomal dominant polycystic kidney disease (ADPKD)
  • Urinary tract malformations
  • Major congenital anomalies of other organ systems

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Monitoring

Duration - Up to 8 years or until participants choose to withdraw

Participants who choose to join the study provide access to their past, current, and future medical information for review and entry into the research database. This includes clinic notes, lab results, and physician reports.

Sample Collection

Duration - One-time or as needed

Optional collection of genetic material including blood or saliva samples from participants and their parents for DNA analysis and storage at the Biorepository.

1 to 3 sample collections depending on family participation

Sample Collection

Duration - Occurs during relevant medical procedures, as available

Optional donation of tissue samples during medical procedures such as autopsy or nephrectomy/hepatectomy for storage and future research use.

1 visit coordinated with medical procedure

Trial Site Locations

Total: 6 locations

1

Children's National Hospital

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

2

Emory

Atlanta, Georgia, United States, 30322

Actively Recruiting

3

Boston Children's

Boston, Massachusetts, United States, 02115

Enrolling by Invitation

4

Cincinnati Children's

Cincinnati, Ohio, United States, 45229

Enrolling by Invitation

5

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19146

Actively Recruiting

6

University of Utah

Salt Lake City, Utah, United States, 84108

Actively Recruiting

Loading map...

Research Team

J

Jasmine Jaber

L

Lisa M Guay-Woodford, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Evaluation of the Diagnostic Performance of Non-Invasive Pre...

Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including

Actively Recruiting

1 location

GROWing Up With Rare GENEtic Syndromes When Children With Co...

Prader-Willi Syndrome

Actively Recruiting

1 location

Imaging Assessments of ARPKD Kidney Disease Progression

Autosomal Recessive Polycystic Kidney Disease

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here